In a word, our results have profound implications for understanding the structural basis underlying mechanism of GPR17 and may provide rational, structure‐based, approaches for ligand screening on GPR17 for the treatment of neurodegenerative diseases. The gene discussed is GPR17; the disease is neurodegenerative disease.